Cited by 516Chronic Obstructive Pulmonary Disease (COPD) ResearchMedication Adherence and ComplianceInhalation and Respiratory Drug Delivery

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Adherence to inhaled therapy, mortality and hospital admission in COPD

Open access

Vestbo, J, Anderson, J A, Calverley, P M A, Celli, B, Ferguson, G T, Jenkins, C, Knobil, K, Willits, L R, Yates, J C, Jones, P W·2009·Thorax

DOI 10.1136/thx.2009.113662

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: Little is known about adherence to inhaled medication in chronic obstructive pulmonary disease (COPD) and the impact on mortality and morbidity. METHODS: Data on drug adherence from a randomised double-blind trial comparing inhaled salmeterol 50 microg + fluticasone propionate 500 microg twice daily with placebo and each drug individually in 6112 patients with moderate to severe COPD over 3 years in the TORCH study were used. All-cause mortality and exacerbations leading to hospital admission were primary and secondary end points. The study of adherence was not specified a priori as an ancillary study. RESULTS: Of the 4880 patients (79.8%) with good adherence defined as >80% use of study medication, 11.3% died compared with 26.4% of the 1232 patients (20.2%) with poor adherence. The annual rates of hospital admission for exacerbations were 0.15 and 0.27, respectively. The association between adherence and mortality remained unchanged and statistically significant after adjusting for other factors related to prognosis (hazard ratio 0.40 (95% CI 0.35 to 0.46), p<0.001). The association was even stronger when analysing on-treatment deaths only. Similarly, the association between adherence and hospital admission remained unchanged and significant in a multivariate analysis (rate ratio 0.58 (95% CI 0.44 to 0.73, p<0.001). The association between increased adherence and improved mortality and reduction in hospital admission was independent of study treatment. The effect of treatment was more pronounced in patients with good adherence than in those with poor adherence. CONCLUSION: Adherence to inhaled medication is significantly associated with reduced risk of death and admission to hospital due to exacerbations in COPD. Further research is needed to understand these strong associations.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1136/thx.2009.113662

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
Self-citation
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: GOLD Executive Summary
Rabe, K. F., Hurd, S., Anzueto, A., Barnes, P. J., Buist, S. A., Calverley, P., Fukuchi, Y., Jenkins, C., Rodriguez-Roisin, R., van Weel, C., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200703-456so · Cited by 4,925
Self-citation
Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
CALVERLEY, P. M. A., Anderson, J. A., Celli, B. R., Ferguson, G. T., Jenkins, C. R., Jones, P., Yates, J., & Vestbo, J. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063070 · Cited by 3,234
Self-citation
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary
Rodríguez, R. (2007) · Cited by 1,412
A meta-analysis of the association between adherence to drug therapy and mortality
Simpson, S. H., Eurich, D. T., Majumdar, S. R., Padwal, R. S., Tsuyuki, R. T., Varney, J., & Johnson, J. A. (2006) · BMJ · doi:10.1136/bmj.38875.675486.55 · Cited by 1,353 · cited 3×
“treatment with a drug with positive effects to that in patients receiving placebo.(1) Most of the studies”
BackgroundMethodResultInfluential
Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study
Garcia-Aymerich, J., Lange, P., Benet, M., Schnohr, P., & Anto, J. M. (2006) · Thorax · doi:10.1136/thx.2006.060145 · Cited by 1,113
Mortality in COPD: role of comorbidities
Sin, D. D., Anthonisen, N. R., Soriano, J. B., & Agusti, A. G. (2006) · European Respiratory Journal · doi:10.1183/09031936.00133805 · Cited by 1,052
Reduction of Hospital Utilization in Patients With Chronic Obstructive Pulmonary Disease A Disease-Specific Self-management Intervention
Bourbeau, J. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.5.585 · Cited by 933
The Handbook of health behavior change
(2009) · Choice Reviews Online · doi:10.5860/choice.46-6233 · Cited by 616
Patterns of Comorbidities in Newly Diagnosed COPD and Asthma in Primary Care
Soriano, J. B., Visick, G. T., Muellerova, H., Payvandi, N., & Hansell, A. L. (2005) · Chest · doi:10.1378/chest.128.4.2099 · Cited by 615

Flagged first, then by citations

Show all 32 references

Sorted by citations

Items 401–500 of 514

Artificial Intelligence and Computational Modeling in Orally Inhaled Drugs
Li, R., Miao, H., Zhou, X., Zou, R., & Tong, Z. (2024) · doi:10.1002/9781119987260.ch11 · Cited by 2
Medication Safety in Chronic Lung Disease with Cardiac Comorbidity
Pleasants, R. A. (2020) · Respiratory medicine · doi:10.1007/978-3-030-43435-9_10 · Cited by 1
Treatment Patterns, Healthcare Utilization and Clinical Outcomes of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Inhaler Long-Acting β2-Agonist/Long-Acting Muscarinic Antagonist Dual Therapy in Primary Care in England
Requena, G., Banks, V., Czira, A., Wood, R. P., Tritton, T., Wild, R., Compton, C. H., & Ismaila, A. (2023) · International Journal of COPD · doi:10.2147/copd.s389281 · Cited by 1
Respiratory Therapy with Digital Inhalers: Insights from Multimodal Experimental and In Vitro Analysis
Gonzalez, D. N., Grinovero, M., Ponti, L., Cova, C., Sesana, V., Franza, M., Citterio, M., & Baschung, Y. (2025) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2024.0042 · Cited by 1
Single-Inhaler Triple Therapy (SITT) for COPD: An Italian expert opinion paper on improving clinical outcomes and equity of therapeutic access
Bianco, A., D'Antonio, S., Lombardo, F. P., Micheletto, C., Palcic, S., Siscaro, G., & Pirina, P. (2026) · Multidisciplinary Respiratory Medicine · doi:10.5826/mrm.2026.1070 · Cited by 1
Inhaled Corticosteroid Escalation After a Single Moderate Exacerbation in COPD : Differential Benefit by Exacerbation Subtype
Shin, S. H., Heo, J., Jung, J. Y., Cho, J., Singh, D., Kang, D., & Park, H. Y. (2026) · Respirology · doi:10.1002/resp.70300 · Cited by 1
Prediction of Postoperative Lung Function
Hun, S. (2012) · InTech eBooks · doi:10.5772/23628 · Cited by 1
AIMAR survey on complex forms of bronchial asthma and COPD, their management and perception of critical issues
Donner, C. F., & Visconti, A. (2014) · Multidisciplinary Respiratory Medicine · doi:10.1186/2049-6958-9-52 · Cited by 1
The Patient Candidate for Long-Term Oxygen Therapy
Negro, R. D. D., & Hodder, R. (2012) · Springer eBooks · doi:10.1007/978-88-470-2580-6_1 · Cited by 1
GOLD Reports on Chronic Obstructive Pulmonary Disease (COPD): Evolutions, Revolutions and Controversies
Vogelmeier, C. F., Criner, G. J., & Roche, N. (2019) · Barcelona Respiratory Network · doi:10.23866/brnrev:2018-0006 · Cited by 1
Teaching the Practical Skill of Correct Inhaler Use: Knowing and Being Able to Do
Faulkner, G. G., II, & Moore, C. J. (2020) · Respiratory medicine · doi:10.1007/978-3-030-44889-9_13 · Cited by 1
Factors Associated with Adherence to Medication among Chronic Obstructive Pulmonary Disease Patients in Tertiary Care Hospital of Nepal: A Cross-Sectional Study
Neupane, S., Thapa, P., Giri, A., Shrestha, S., & Marasine, N. R. (2020) · Journal of Pharmaceutical Research International · doi:10.9734/jpri/2020/v32i2030737 · Cited by 1
A Clinical Trial of the Relationship Between Anxiety and Lung Function and Respiratory Symptoms in Patients with Asthma, Copd and Copd-Asthma. Assessment of Life Quality
Ţîrcă, S. M., Ciontea, M. S., Vlad, E., & Mihaltan, F. D. (2022) · Internal Medicine · doi:10.2478/inmed-2022-0195 · Cited by 1
Enhancing the diagnosis and management of COPD in Primary care
Partridge, M. R. (2014) · Multidisciplinary Respiratory Medicine · doi:10.4081/mrm.2014.397 · Cited by 1
COPD 2013: An update on treatment and newly approved medications for pharmacists
Meyer, K. C. (2013) · Pharmacy Today · doi:10.1016/s1042-0991(15)31111-7 · Cited by 1
SPUR: A Patient-Reported Medication Adherence Model as a Predictor of Admission and Early Readmission in Patients Living with Type 2 Diabetes
Wells, J. S., Wang, C., Dolgin, K., & Kayyali, R. (2023) · Patient Preference and Adherence · doi:10.2147/ppa.s397424 · Cited by 1
Comparative Effectiveness of Umeclidinium/Vilanterol versus Inhaled Corticosteroid/Long-Acting β2-Agonist in Patients with Chronic Obstructive Pulmonary Disease in a Primary Care Setting in England
Czira, A., Requena, G., Banks, V., Wood, R. P., Tritton, T., Castillo, C. M., Yeap, J., Wild, R., Compton, C. H., Rothnie, K., et al. (2023) · International Journal of COPD · doi:10.2147/copd.s405498 · Cited by 1
Evaluating dry powder inhalers: From in vitro studies to mobile health technologies
Ari, A., & Alhamad, B. R. (2023) · Respiratory Medicine · doi:10.1016/j.rmed.2023.107281 · Cited by 1
Patient and social factors related to nebulizer use in COPD patients at the transition of care: a qualitative study
Foster, A. A., Stoll, J., Daly, C. J., Clark, C. M., Sethi, S., & Jacobs, D. M. (2023) · BMC Pulmonary Medicine · doi:10.1186/s12890-023-02651-w · Cited by 1
Improved medication adherence in COPD patients using tiotropium or tiotropium olodaterol with the HealthPrize digital behavior change program
Firlik, K. S., Anupindi, V. R., Hayes, V., DeKoven, M., Shaikh, A., & Franchino‐Elder, J. (2023) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2023.2296561 · Cited by 1
The association between comprehensive medication review and medication adherence among medicare beneficiaries with chronic obstructive pulmonary disease
Zhang, X., Sim, Y., Tsang, C. C. S., Wang, J., & Finch, C. K. (2024) · Exploratory Research in Clinical and Social Pharmacy · doi:10.1016/j.rcsop.2024.100470 · Cited by 1
A hospital-based exploration of medication adherence among outpatients with COPD: implications for clinical practice
Jarab, A. S., Al-Qerem, W. A., Alzoubi, K. H., Heshmeh, S. A., Momany, E. M. A., Hamarneh, Y. N. A., Mukattash, T. L., Eberhardt, J., Aburuz, S., & Akour, A. A. (2025) · Pharmacy Practice · doi:10.18549/pharmpract.2025.2.3142
Device adherence and user experience with daily home-based FeNO monitoring (Vivatmo me) in asthma patients: the FeNO@home observational study
Beeh, K. M., Heffler, E. M., Timmermann, H., Weber, S., Schneider, A., & Wegner, S. (2025) · BMC Digital Health · doi:10.1186/s44247-025-00212-1 · Cited by 1
Should Medicare rely on high drug spending as a criterion for medication therapy management programmes?
Simoni, J. M., Qian, J., Wei, Y. J., Stuart, B., Zuckerman, I. H., Shaffer, T., Dalal, A. A., & Bryant‐Comstock, L. (2012) · Journal of Pharmaceutical Health Services Research · doi:10.1111/j.1759-8893.2012.00102.x · Cited by 1
Fluticasone furoate/vilanterol dry-powder inhaler: a guide to its use in chronic obstructive pulmonary disease
McKeage, K. (2015) · Drugs & Therapy Perspectives · doi:10.1007/s40267-015-0195-z · Cited by 1
Management of chronic obstructive pulmonary disease: criteria for an appropriate hospital discharge
Candela, M., Pastorelli, R., Sacchetta, A., Campanini, M., Fabbri, L. M., & Nozzoli, C. (2013) · Italian Journal of Medicine · doi:10.4081/itjm.2013.218 · Cited by 1
Effect of Implementing an Educational Module About Inhaler Use on Severity of Dyspnea and Adherence to Inhalation Therapy Among Patients with Chronic Obstructive Pulmonary Disease
Weheida, S. M. (2017) · American Journal of Nursing Science · doi:10.11648/j.ajns.20170601.16 · Cited by 1
PROGRESS AND PROSPECTS FOR LONG-ACTING β 2 -AGONISTS IN THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
PUXEDDU, E., Ora, J., Calzetta, L., & CAZZOLA, M. (2018) · The Bulletin of Contemporary Clinical Medicine · doi:10.20969/vskm.2018.11(1).70-78 · Cited by 1
Die überschätzte Beeinflussung der Exazerbationsrate bei COPD durch Inhalativa (LABA, LAMA, ICS)
Köhler, D., & Dellweg, D. (2017) · Pneumologie · doi:10.1055/s-0043-118889 · Cited by 1
Budesonide/formoterol therapy: effective and appropriate use in asthma and chronic obstructive pulmonary disease
Mapel, D. W., Roberts, M. H., & Davis, J. R. (2020) · Journal of Comparative Effectiveness Research · doi:10.2217/cer-2019-0161 · Cited by 1
Transitioning Aerosol from Hospital to Home; Role of Training and Follow-Up
Abdelrahim, M. E. A., Saeed, H., Harb, H. S., & Madney, Y. M. (2021) · Springer eBooks · doi:10.1007/978-3-030-85026-5_5 · Cited by 1
So That's How You Use It: How Effective Is Education on Inhaler Use?
Faulkner, G. G., II (2017) · Respiratory Care · doi:10.4187/respcare.05687 · Cited by 1
Children’s High Adherence to Asthma Biologics: Exceptional or Simply Logical?
Carroll, W. D., & van Boven, J. F. M. (2026) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2025.10.035 · Cited by 1
Impacto da atenção farmacêutica na avaliação da técnica inalatória, aderência ao tratamento, controle clínico e qualidade de vida em portadores de asma e doença pulmonar obstrutiva crônica (DPOC)
Santos, D. D. O. (2010) · doi:10.11606/d.5.2010.tde-03112010-171418
Wirkungen der Bronchodilatation mit Salmeterol auf das autonome Nervensystem
Bornemann, T. (2015) · doi:10.53846/goediss-4730
Prescribing established and new therapies in COPD
Bostock-Cox, B. (2012) · Nurse Prescribing · doi:10.12968/npre.2012.10.11.539
A homeopathic remedy for early COPD
Enright, P. (2011) · Respiratory Medicine · doi:10.1016/j.rmed.2011.08.005
A Review of Salmeterol–Fluticasone Propionate in Combination: Its Use in the Treatment of Chronic Obstructive Pulmonary Disease
Ohbayashi, H. (2011) · Clinical Medicine Reviews in Therapeutics · doi:10.4137/cmrt.s1586
"Show me the money": a fair criticism of economic studies on inhaled bronchodilators for COPD
Κostikas, Κ., & Bouros, D. E. (2010) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-10-48
Telehealth: a case study in a large GP practice
Bosanquet, N., Gora, L., & Markey, D. (2013) · British Journal of Healthcare Management · doi:10.12968/bjhc.2013.19.4.170
Travelling in time with COPD
Hurst, J. R., & Calverley, P. M. A. (2010) · Thorax · doi:10.1136/thx.2010.146811
Self-citation
Impact of Coexistence of Chronic Obstructive Pulmonary Disease and Cognitive Impairment on Mortality and Hospitalization of Elderly People
Zito, A., & Incalzi, R. A. (2013) · Aging Health · doi:10.2217/ahe.12.79
Chronic Pulmonary Diseases Across the Life Span
Dempsey, A. G., Duncan, C. L., & Kania, K. M. (2014) · Springer eBooks · doi:10.1007/978-0-387-09817-3_20
Impacto de las nuevas opciones terapéuticas en la EPOC
Agustí, A. G. N. (2010) · Archivos de Bronconeumología · doi:10.1016/s0300-2896(10)70045-4
Dispositivos inhaladores en la EPOC: ¿Cuál utilizar?
López García, F., & Bas Reina, C. (2015) · Galicia Clínica · doi:10.22546/32/758
Multidisciplinary Disease Management Program for Patients with Chronic Obstructive Pulmonary Disease
Sankari, A., Dingell, J. D., & John, R. P. (2014)
Original article Therapy persistence and adherence in patients with chronic obstructive pulmonary disease: multiple versus single long-acting maintenance inhalers
Yu, A. P., Guérin, A., de Leon, D. P., Ramakrishnan, K., Wu, E. Q., Mocarski, M., Blum, S., & Setyawan, J. (2011)
STUD Y PRO TO COL FULL TEXT ARTICLE Study protocol for a randomized, controlled trial comparing the efficacy of two educational interventions to improve inhalation techniques in patients with chronic obstructive pulmonary disease (COPD): TIEPOC Study
Leiva-Fernández, J., Leiva-Fernández, F., Vazquez-Alarcon, R., Ruíz, A., Prados-Torres, D., & Barnestein‐Fonseca, P. (2014)
Chronic Obstructive Pulmonary Disease 3 Controversies in treatment of chronic obstructive pulmonary disease
Rabe, K. F., Wedzicha, J. A., & Albrechts, C. (2011)
Corrigendum to ‘The use of roflumilast in COPD: a primary care perspective’ (Prim Care Resp J 2010;19(4) (Suppl 2):342–351)
Price, D. B., Chisholm, A., Ryan, D. P., Crockett, A. J., & Jones, R. C. M. (2011) · Primary Care Respiratory Journal · doi:10.4104/pcrj.2011.00019
Current optimization of combined therapy for chronic obstructive pulmonary disease
Popova, E. N. (2015) · Terapevticheskii arkhiv · doi:10.17116/terarkh20158712107-110
Which inhaler device in COPD
Garcı́a, F. L., & Reina, C. B. (2015)
Atenção farmacêutica ao paciente portador de asma e Doença Pulmonar Obstrutiva Crônica: coletânea de estudos sobre adesão, uso de inaladores, sistematização da atenção e perfil farmacoepidemiológico
Simões, L. Z. (2016) · doi:10.11606/d.5.2016.tde-03022016-091334
Avaliação da adesão, índice de complexidade de medicamentos e técnica de uso de dispositivos inalatórios em pacientes com doença pulmonar obstrutiva crônica
Diniz, N. O. (2014) · Americanae (AECID Library)
INDIVIDUALIZED APPROACH, EVIDENCE, PRACTICE (BASED ON PROCEEDINGS OF THE 26TH NATIONAL CONGRESS ON RESPIRATORY DISEASES)
Barabanova, E. N. (2016) · PULMONOLOGIYA · doi:10.18093/0869-0189-2016-26-5-630-634
The role of pulmonary rehabilitation in the prevention of exacerbations of chronic lung diseases
Rodrigues, F. M. M., Loeckx, M., Troosters, T., & Janssens, W. (2017) · European Respiratory Society eBooks · doi:10.1183/2312508x.10016916 · Cited by 1
Etterlevelse av behandlingsprogrammer hos pasienter med kronisk sykdom
Bentsen, S. B. (2013) · Nordisk Sygeplejeforskning · doi:10.18261/issn1892-2686-2013-03-06
Adherence to inhaled medication in COPD : predictors and outcomes
Huurne, K. K.-T. (2018) · doi:10.3990/1.9789036545440
ASSESSING THE IMPACT OF PRESCRIPTION OPIOID USE VERSUS NO USE ON ADHERENCE TO CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) MAINTENANCE MEDICATIONS, COPD EXACERBATIONS AND TOTAL HEALTHCARE COSTS
Kharat, A. A. (2018) · UNM’s Digital Repository (University of New Mexico)
Physical activity in COPD
Raste, Y. (2016) · Spiral (Imperial College London) · doi:10.25560/55133
Adherence to inhaler treatments in obstructive lung diseases: A different perspectivePreprint
Aksu, F., Aksu, K., Tezvergil, T., & Fırıncıoğluları, A. (2020) · doi:10.22541/au.160157492.22805245
Digitalization of Pneumological Care in the Outpatient Sector: An Inventory
Schlesinger, A. (2021) · Future of business and finance · doi:10.1007/978-3-030-65896-0_10
Analysis of the characteristics of patients admitted to Internal Medicine wards for exacerbation of chronic obstructive pulmonary disease, and discharge phase optimization. The SDO-ARCA Project of the Scientific Society FADOI
Candela, M., Norbiato, C., Campanini, M., Brucato, A. L., Simone, S. D., Manfellotto, D., Dentali, F., Sacchetta, A., Valerio, A., & Fontanella, A. (2020) · Italian Journal of Medicine · doi:10.4081/itjm.2020.1321
Long term effects of a standard Mindfulness Based Stress Reduction program in COPD patients
Bensliman, S., Ninane, V., Bradstreet, N., & Mélot, C. (2021) · SCIREA Journal of Clinical Medicine · doi:10.54647/cm32615
Digitalisierung: Trends in der Pneumologie
Häußermann, S. (2020) · Deutsches Ärzteblatt · doi:10.3238/perspneumo.2020.02.14.07
Adherence to Inhaler Treatments: Statement of Patients and Their Relatives: Cross-Sectional Study
Aksu, F., Aksu, K., Tezvergil, T., & Fırıncıoğluları, A. (2022) · Turkiye Klinikleri Archives of Lung · doi:10.5336/archlung.2021-87724
Trouwe placebogebruikers leven langer
(2010) · Huisarts en Wetenschap · doi:10.1007/bf03089244
PROGRESS AND PROSPECTS FOR LONG-ACTING β 2 -AGONISTS IN THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
PUXXEDU, E., Ora, J., Calzetta, L., & CAZZOLA, M. (2017) · The Bulletin of Contemporary Clinical Medicine · doi:10.20969/vskm.2017.10(1).7-14
AIMAR survey on complex forms of bronchial asthma and COPD, their management and perception of critical issues
Donner, C. F., & Visconti, A. (2014) · Multidisciplinary Respiratory Medicine · doi:10.4081/mrm.2014.387
8th International Conference on Management and Rehabilitation of Chronic Respiratory Failure: the Long Summaries
Ambrosino, N., Casaburi, R. H., Chetta, A. A., Clini, E. M., Donner, C. F., Dreher, M., Goldstein, R. S., Jubran, A., Nici, L. L., Owen, C. A., et al. (2015) · Multidisciplinary Respiratory Medicine · doi:10.4081/mrm.2015.324
Pediatric outpatients from a bronchopulmonary medicine service in a public hospital in Chile: assessment of the adherence and inhalation technique
Vega, E. M., & Ayala, G. C. (2022) · Pharmacy & Pharmacology International Journal · doi:10.15406/ppij.2022.10.00365
Improving care for patients with cardiorespiratory conditions
Bosanquet, N. (2022) · British Journal of Healthcare Management · doi:10.12968/bjhc.2022.0103
Diagnosis and general approaches to the treatment of chronic obstructive pulmonary disease
Gubanov, D. S., & Gubanova, K. M. (2022) · Tambov Medical Journal · doi:10.20310/2782-5019-2022-4-3-19-32
Optimising Clinical Outcomes in Asthma and Chronic Obstructive Pulmonary Disease: Focus on Inhaler Satisfaction and Patient Adherence
Thorne, J. (2019) · EMJ Respiratory · doi:10.33590/emjrespir/10312088
Adherence to treatment recommendations of patients with chronic non-communicable respiratory diseases – a narrative review
Homętowska, H. (2023) · Journal of Education Health and Sport · doi:10.12775/jehs.2023.13.04.020
Device Matters: Looking Beyond the Drug
Hesp, B. R. (2016) · EMJ Respiratory · doi:10.33590/emjrespir/10313970
Investigation of two treatment regimens in adults with mild asthma
Baggott, C. (2020) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.17149109
A Prospective Observational Study on Prescribing Pattern of Inhalers and Evaluating the Adherence to Inhalational Technique in Patients with Obstructive Lung Disease
BHAGYARAJ, R. , PRASOBH.GR, Mammen, A. S., -, S. L. R., JEEMA, M. , & -, F. J. (2023) · International Journal For Multidisciplinary Research · doi:10.36948/ijfmr.2023.v05i03.3011
Digital strategies to support adherence to medication in asthma and COPD
Dierick, B. J. H. (2023) · doi:10.33612/diss.799517156
Medication use of Canadians with chronic obstructive pulmonary disease: a cohort study
Stickland, M. K., Martins, K. J. B., Sharpe, H. M., Vu, K. N., Bhutani, M., Walker, B., Williamson, T. S., Bohlouli, S., Richer, L. P., & Klarenbach, S. W. (2023) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2023-002083
Evaluation of impact of adherence to inhaled therapy and critical mistakes in inhalation technique on clinical outcomes in patients with obstructive airway diseases in India
Godse, A., Gurjar, R., Rao, N., Gore, S., & Vijay, R. (2024) · IP Indian Journal of Immunology and Respiratory Medicine · doi:10.18231/j.ijirm.2024.013
Treatment Adherence and Health Status of Patients With COPD Under Treatment With Salmeterol/Fluticasone via the Elpenhaler® Device: The AHEAD Study
Exarchos, K., Hillas, G., Steiropoulos, P., Papanastasiou, P., Gogali, A., & Kostikas, K. (2024) · The Clinical Respiratory Journal · doi:10.1111/crj.13803
Investigating influencing factors of medication adherence to inhalers in COPD patients: A study based on the Anderson modelPreprint
Yin, C., Luo, Y., Shen, K., Mao, G., & Tang, F. (2024) · Research Square · doi:10.21203/rs.3.rs-5302708/v1
Pharmaceutical care needs of patients with chronic respiratory diseases：results from a cross sectional studyPreprint
Zhang, J., Zhang, S., Lin, Q., Li, Y., Liu, M., & Yang, M. (2025) · Research Square · doi:10.21203/rs.3.rs-6702396/v1
Inhaler identification: evaluating a potential screening method for adherence in chronic respiratory disease management
Gomes, D. S., Seixas, C., & Cravo, J. M. (2025) · Jornal Brasileiro de Pneumologia · doi:10.36416/1806-3756/e20250393
Chronic Obstructive Pulmonary Disease Case Finding: Severity Grade at First Spirometry and Ongoing Therapy 12 Months after Initial Diagnosis
Milanese, M., Cavaliere, A., Cavallaro, G., Corti, L., Longagna, A., Morando, A., & Cirone, M. (2025) · Respiration · doi:10.1159/000547705
Fixed-dose bronchodilator combinations in chronic obstructive pulmonary disease: focus on indacaterol/ glycopyrronium
Айсанов, З. Р., & Lyushin, D. Y. (2025) · PULMONOLOGIYA · doi:10.18093/0869-0189-2025-35-4-577-586
Determinants of exacerbation frequency in COPD
Quint, J. K. (2010) · UCL Discovery (University College London)
Additional file 1 of Cost-utility analysis of transitional care services for older inpatients with chronic obstructive pulmonary disease (COPD) in Korea
Hwang, Y. S., Kim, W. J., Kim, T. H., Park, Y., Jung, S. M., & Jo, H. S. (2024) · Figshare · doi:10.6084/m9.figshare.25330850
Additional file 2 of Cost-utility analysis of transitional care services for older inpatients with chronic obstructive pulmonary disease (COPD) in Korea
Hwang, Y. S., Kim, W. J., Kim, T. H., Park, Y., Jung, S. M., & Jo, H. S. (2024) · Figshare · doi:10.6084/m9.figshare.25330889
Additional file 2 of Impact of removing prescription co-payments on the use of costly health services: a pragmatic randomised controlled trial
Norris, P., Cousins, K., Horsburgh, S., Keown, S., Churchward, M., Samaranayaka, A., Smith, A. S., & Marra, C. A. (2023) · Figshare · doi:10.6084/m9.figshare.22614346
Additional file 1 of Cost-related medication nonadherence in adults with COPD in the United States 2013–2020
Wen, X., Qiu, H., Yu, B., Bi, J., Gu, X., Zhang, Y., & Wang, S. (2024) · Figshare · doi:10.6084/m9.figshare.26696001
Additional file 4 of Cost-utility analysis of transitional care services for older inpatients with chronic obstructive pulmonary disease (COPD) in Korea
Hwang, Y. S., Kim, W. J., Kim, T. H., Park, Y., Jung, S. M., & Jo, H. S. (2024) · Figshare · doi:10.6084/m9.figshare.26687870
Additional file 1 of Pharmacist involvement in the inhaler choice improves lung function in patients with COPD: a prospective single-arm study
Shiwaku, E., Dote, S., Kaneko, S., Hei, C., Aikawa, M., Sakai, Y., Kawai, T., Iwatsubo, S., Hashimoto, M., Tsuneishi, T., et al. (2021) · Figshare · doi:10.6084/m9.figshare.15088534
Additional file 1 of Impact of removing prescription co-payments on the use of costly health services: a pragmatic randomised controlled trial
Norris, P., Cousins, K., Horsburgh, S., Keown, S., Churchward, M., Samaranayaka, A., Smith, A. S., & Marra, C. (2023) · Figshare · doi:10.6084/m9.figshare.22614343
Additional file 1 of Patient and social factors related to nebulizer use in COPD patients at the transition of care: a qualitative study
Foster, A. A., Stoll, J., Daly, C. J., Clark, C. M., Sethi, S., & Jacobs, D. M. (2023) · Figshare · doi:10.6084/m9.figshare.24186083
Additional file 1 of Time-to-first exacerbation, adherence, and medical costs among US patients receiving umeclidinium/vilanterol or tiotropium as initial maintenance therapy for chronic obstructive pulmonary disease: a retrospective cohort study
Slade, D., Ray, R., Moretz, C., Germain, G., Laliberté, F., Shen, Q., Duh, M. S., Mahendran, M., & Hahn, B. A. (2021) · Figshare · doi:10.6084/m9.figshare.15087424
Additional file 3 of Cost-utility analysis of transitional care services for older inpatients with chronic obstructive pulmonary disease (COPD) in Korea
Hwang, Y. S., Kim, W. J., Kim, T. H., Park, Y., Jung, S. M., & Jo, H. S. (2024) · Figshare · doi:10.6084/m9.figshare.26687867
Additional file 1 of Efficacy and safety of CHF6001, a novel inhaled PDE4 inhibitor in COPD: the PIONEER study
Singh, D., Emirova, A., Francisco, C., Santoro, D., Govoni, M., & Nandeuil, M. A. (2020) · Figshare · doi:10.6084/m9.figshare.12991796
Association between metered-dose inhaler confidence and misuse among adults with asthma or chronic obstructive pulmonary disease
Liyanage-Don, N. A., Zajac, P., Jackson‐Sagredo, A., Zhu, M., & Press, V. G. (2026) · Annals of the American Thoracic Society · doi:10.1093/annalsats/aaoaf069

Authors: Vestbo, J., Anderson, J. A., Calverley, P. M. A., Celli, B., Ferguson, G. T., Jenkins, C., Knobil, K., Willits, L. R., Yates, J. C., & Jones, P. W.
Affiliations: University of Manchester (GB)
GlaxoSmithKline (United Kingdom) (GB)
Aintree University Hospital (GB)
Tufts University (US)
Woolcock Institute of Medical Research (AU)
GlaxoSmithKline (United States) (US)
St George's, University of London (GB)
Corresponding author: Vestbo, J
ORCID: Vestbo, J
Anderson, J A
Calverley, P M A
Celli, B
Ferguson, G T
Jenkins, C
Yates, J C
Jones, P W
Venue: Thorax
Publisher: BMJ
Published: 2009-08-23
Volume: 64
Issue: 11
Pages: 939-943
ISSN: 0040-6376 (ISSN-L)
DOI: 10.1136/thx.2009.113662
OpenAlex: W2095666112
Cited by: 516
References: 32
Citations by year: 2026: 17 · 2025: 22 · 2024: 36 · 2023: 35 · 2022: 30 · 2021: 34 · 2020: 45 · 2019: 36 · 2018: 33 · 2017: 32 · 2016: 31 · 2015: 35 · 2014: 45 · 2013: 31 · 2012: 17
FWCI: 15.15
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Thorax (publishedVersion)
PubMed (publishedVersion)
Research Explorer (The University of Manchester) (publishedVersion)
HighWire Press Open Archive (submittedVersion)
Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
Topics: Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
Keywords: chronic obstructive pulmonary disease, medication adherence, inhalation therapy, salmeterol, fluticasone propionate, all-cause mortality, hospitalization, COPD exacerbations, TORCH trial
MeSH terms: Fluticasone, Salmeterol Xinafoate, Administration, Inhalation, Adult, Aged, Aged, 80 and over, Albuterol, Androstadienes, Bronchodilator Agents, Drug Administration Schedule, Drug Combinations, Drug Therapy, Combination, Epidemiologic Methods, Female, Hospitalization, Humans, Male, Middle Aged, Pulmonary Disease, Chronic Obstructive, Medication Adherence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Adherence to inhaled therapy, mortality and hospital admission in COPD

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks